Highly selective and potent inhibitor of integrin α4β1
(Very Late Antigen-4; VLA-4) (Kd
< 10 pM). Selectively binds α4β1
over a range of other integrins (IC50
values are 1.8, 138, 1053, > 500 and > 10,000 nM for α4β1
, respectively). Induces a 30-fold increase in mobilization of murine hematopoietic stem and progenitor cells; displays a 3-fold additive effect with AMD 3100
(Cat. No. 3299).
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
An assessment of the mechanistic differences between two integrin α4β1 inhibitors, the monoclonal antibody TA-2 and the small molecule BIO5192, in rat experimental aut
Leone et al.
A chemical approach to stem-cell biology and regenerative medicine.
Xu et al.
BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells.
Ramirez et al.